Elevance Health, Inc. (ELV) Q2 2026 Earnings Call Transcript
Elevance Health, Inc. (ELV) Q2 2026 Earnings Call Transcript
Seeking Alpha7/15/2026Neutral
ELV
Elevance Health IncNYSEHEALTHCAREHEALTHCARE PLANS
Key Statistics
Market Cap
$80.97B
P/E Ratio
16.50
EPS
$22.60
Beta
0.68
52W High
$436.24
52W Low
$268.08
50-Day MA
$397.96
200-Day MA
$348.93
Dividend Yield
0.88%
Profit Margin
2.47%
Forward P/E
15.87
PEG Ratio
1.56
About Elevance Health Inc
Elevance Health Inc. is a health benefits company. The company is headquartered in Indianapolis, Indiana.
Fundamentals
| Revenue (TTM) | $201.11B |
| Gross Profit (TTM) | $52.27B |
| EBITDA | $8.20B |
| Operating Margin | 4.56% |
| Return on Equity | 11.10% |
| Return on Assets | 3.77% |
| Revenue/Share (TTM) | $912.91 |
| Book Value | $201.97 |
| Price-to-Book | 2.10 |
| Price-to-Sales (TTM) | 0.46 |
| EV/Revenue | 0.571 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -13.10% |
| Quarterly Revenue Growth (YoY) | 1.40% |
| Shares Outstanding | $217.16M |
| Float | $217.44M |
| % Insiders | 0.18% |
| % Institutions | 93.52% |
Historical Volatility
HV 10-Day
55.03%
HV 20-Day
50.76%
HV 30-Day
46.17%
HV 60-Day
39.12%
HV Rank
76.2%
Volatility is currently expanding
Analyst Ratings
Consensus ($447.62 target)
2
Strong Buy12
Buy8
HoldLatest News
ELV Beats Q2 Earnings Estimates on Higher CarelonRx Product Revenues
Elevance Health beats Q2 EPS and revenue estimates, raises 2026 adjusted EPS outlook despite lower earnings, softer membership and higher expenses.
Zacks Investment Research7/15/2026Positive
Elevance Health Q2 Earnings Call Highlights
Elevance Health NYSE: ELV raised its 2026 adjusted earnings outlook after second-quarter results came in ahead of management's expectations, citing favorable benefit expense performance, disciplined cost management and improving execution across several major business lines.
MarketBeat7/15/2026Positive
Compared to Estimates, Elevance Health (ELV) Q2 Earnings: A Look at Key Metrics
The headline numbers for Elevance Health (ELV) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks Investment Research7/15/2026Positive
Elevance Health (ELV) Surpasses Q2 Earnings and Revenue Estimates
Elevance Health (ELV) came out with quarterly earnings of $7.45 per share, beating the Zacks Consensus Estimate of $6.18 per share. This compares to earnings of $8.84 per share a year ago.
Zacks Investment Research7/15/2026Positive
Elevance Health Profits Eclipse $1.4 Billion As Costs Ease Somewhat
Elevance Health reported second quarter net income of $1.45 billion as medical costs fell in some health plans, triggering an improved outlook for the rest of the year.
Forbes7/15/2026Positive
Elevance Health Raises Earnings Outlook on Higher Sales
The health insurer raised its earnings outlook after logging a higher benefit-expense ratio and sales number in the second quarter.
WSJ7/15/2026Positive
Elevance Health Reports Second Quarter 2026 Results; Raises Full-Year Guidance
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported second quarter 2026 results ahead of expectations. "Our second quarter results exceeded our outlook, supported by disciplined execution and improved operating performance across our diversified portfolio. We are raising our 2026 adjusted EPS guidance to at least $27.00 and accelerating targeted investments in the capabilities that matter most: medical cost management, member experience, provider connectivity, operating ef.
Business Wire7/15/2026Neutral
Will Health Benefits Weakness Drag Elevance's Q2 Earnings?
ELV faces Q2 pressure as weaker Health Benefits results and higher benefit expenses may weigh on earnings ahead of its July 15 report.
Zacks Investment Research7/13/2026Negative
Eyes On Elevance Health, UnitedHealth For Continued Insurer Rebound
This week's Elevance Health and UnitedHealth Group quarterly earnings are much anticipated for signs these companies' health insurance businesses and that of their rivals are keeping a handle on rising costs.
Forbes7/13/2026Neutral
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ELV and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 7/17/2026